-
Birth Registrations Plummet in Wake of Ebola Epidemic
Liberia’s Ebola epidemic may have subsided but its after-effects are still being felt, with tens of thousands of infants going unregistered at birth, the U.N. children’s agency UNICEF says.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
A Paper Microscope That Costs Only 50 cents Can Detect Malaria From Just a Drop of Blood – And It Could Revolutionize Medicine
For a whole lot of people, especially those in developing countries, science - and with it, medicine - isn't readily available to the majority of citizens. But Manu Prakash wants to change that.
- Categories
- Health Care
-
When ‘Wonder Drugs’ Aren’t Enough: Viral hepatitis reaches watershed moment, but who will pay?
Debate rages about what constitutes fair pricing practices for a lifesaving drug that could save millions of people – and how to balance affordability and access with sustained investment in R&D, company profits and responsiveness to stakeholders including patients, health care providers, payers and shareholders.
- Categories
- Health Care
-
WHO: Unsafe Injections Major Cause of Hepatitis Death
In advance of World Hepatitis Day (July 28), the World Health Organization is calling for urgent action to curb millions of infections and deaths from viral hepatitis.
- Categories
- Health Care
-
Health Specialists Call for $2 Billion Global Fund for Vaccines
Global health experts called on Wednesday for the creation of a $2 billion vaccine development fund to feed a pipeline of potential new shots against priority killer diseases like Ebola, MERS and the West Nile virus.
- Categories
- Health Care
-
Sanofi Preps for ‘Profitable’ Dengue Vaccine Rollout in 20 Countries
With more than $1.5 billion in development costs and 20 years of research on the line, Sanofi ($SNY) is getting revved up to launch its world-first dengue vaccine later this year. And if the company's predictions are correct, the shot will not only be a big deal for patients in the developing world--it'll be a highly profitable product to boot.
- Categories
- Health Care
-
Partnerships and Innovation to Defeat Malaria: An Interview With Dr. David Reddy
Dr David Reddy is CEO of Medicines for Malaria Venture (MMV), a product development partnership that works with both the public and private sectors to facilitate the discovery, development and delivery of new antimalarial drugs. Before his public lecture held at the Crawford School (presentation available here), Dr Reddy sat down with Camilla Burkot to talk about MMV’s role in tackling malaria. You can listen to the podcast here and read the full transcript here. For a summary of their discussion, read on.
- Categories
- Health Care
-
$100B Plan Seeks to Cut Malaria Cases, Deaths by 90 Percent
Major health, development and financial agencies have unveiled a $100 billion plan to cut global malaria cases and deaths by 90 percent over the next 15 years. The Roll Back Malaria Partnership says its new strategy will result in a health and economic bonanza for developing countries.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.